172 related articles for article (PubMed ID: 23677512)
1. Cerebrospinal fluid and plasma oxidative stress biomarkers in different clinical phenotypes of neuroinflammatory acute attacks. Conceptual accession: from fundamental to clinic.
Ljubisavljevic S; Stojanovic I; Vojinovic S; Stojanov D; Stojanovic S; Kocic G; Savic D; Cvetkovic T; Pavlovic D
Cell Mol Neurobiol; 2013 Aug; 33(6):767-77. PubMed ID: 23677512
[TBL] [Abstract][Full Text] [Related]
2. Erythrocytes' antioxidative capacity as a potential marker of oxidative stress intensity in neuroinflammation.
Ljubisavljevic S; Stojanovic I; Cvetkovic T; Vojinovic S; Stojanov D; Stojanovic D; Stefanovic N; Pavlovic D
J Neurol Sci; 2014 Feb; 337(1-2):8-13. PubMed ID: 24269090
[TBL] [Abstract][Full Text] [Related]
3. The importance of nitric oxide and arginase in the pathogenesis of acute neuroinflammation: are those contra players with the same direction?
Ljubisavljevic S; Stojanovic I; Pavlovic R; Pavlovic D
Neurotox Res; 2014 Nov; 26(4):392-9. PubMed ID: 24770974
[TBL] [Abstract][Full Text] [Related]
4. The Validation Study of Neurofilament Heavy Chain and 8-hydroxy-2'-deoxyguanosine as Plasma Biomarkers of Clinical/Paraclinical Activity in First and Relapsing-Remitting Demyelination Acute Attacks.
Ljubisavljevic S; Stojanovic I; Basic J; Pavlovic DA
Neurotox Res; 2016 Oct; 30(3):530-8. PubMed ID: 27295058
[TBL] [Abstract][Full Text] [Related]
5. The patients with clinically isolated syndrome and relapsing remitting multiple sclerosis show different levels of advanced protein oxidation products and total thiol content in plasma and CSF.
Ljubisavljevic S; Stojanovic I; Vojinovic S; Stojanov D; Stojanovic S; Cvetkovic T; Savic D; Pavlovic D
Neurochem Int; 2013 Jun; 62(7):988-97. PubMed ID: 23500606
[TBL] [Abstract][Full Text] [Related]
6. Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing-remitting multiple sclerosis.
Ahlbrecht J; Martino F; Pul R; Skripuletz T; Sühs KW; Schauerte C; Yildiz Ö; Trebst C; Tasto L; Thum S; Pfanne A; Roesler R; Lauda F; Hecker M; Zettl UK; Tumani H; Thum T; Stangel M
Mult Scler; 2016 Aug; 22(9):1202-14. PubMed ID: 26493127
[TBL] [Abstract][Full Text] [Related]
7. Prognostic relevance of the C-X-C motif chemokine ligand 13 and interleukin-8 in predicting the transition from clinically isolated syndrome to multiple sclerosis.
Klíčová K; Mareš J; Sobek O; Rous Z; Rous M; Raška M; Hartung HP
Eur J Neurosci; 2024 Jun; 59(11):2955-2966. PubMed ID: 38453679
[TBL] [Abstract][Full Text] [Related]
8. Glutathione homeostasis disruption of erythrocytes, but not glutathione peroxidase activity change, is closely accompanied with neurological and radiological scoring of acute CNS inflammation.
Ljubisavljevic S; Stojanovic I; Cvetkovic T; Vojinovic S; Stojanov D; Stojanovic D; Bojanic V; Stokanovic D; Pavlovic D
Neuroimmunomodulation; 2014; 21(1):13-20. PubMed ID: 24135853
[TBL] [Abstract][Full Text] [Related]
9. CXCL10 and CXCL13 chemokines in patients with relapsing remitting and primary progressive multiple sclerosis.
Iwanowski P; Losy J; Kramer L; Wójcicka M; Kaufman E
J Neurol Sci; 2017 Sep; 380():22-26. PubMed ID: 28870573
[TBL] [Abstract][Full Text] [Related]
10. Degenerative and inflammatory markers in the cerebrospinal fluid of multiple sclerosis patients with relapsing-remitting course of disease and after clinical isolated syndrome.
Sladkova V; Mareš J; Lubenova B; Zapletalova J; Stejskal D; Hlustik P; Kanovsky P
Neurol Res; 2011 May; 33(4):415-20. PubMed ID: 21535941
[TBL] [Abstract][Full Text] [Related]
11. Association of serum bilirubin and uric acid levels changes during neuroinflammation in patients with initial and relapsed demyelination attacks.
Ljubisavljevic S; Stojanovic I; Vojinovic S; Milojkovic M; Dunjic O; Stojanov D; Pavlovic D
Metab Brain Dis; 2013 Dec; 28(4):629-38. PubMed ID: 23606133
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis.
Novakova L; Axelsson M; Khademi M; Zetterberg H; Blennow K; Malmeström C; Piehl F; Olsson T; Lycke J
J Neurochem; 2017 Apr; 141(2):296-304. PubMed ID: 27787906
[TBL] [Abstract][Full Text] [Related]
13. Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis.
Brettschneider J; Petzold A; Junker A; Tumani H
Mult Scler; 2006 Apr; 12(2):143-8. PubMed ID: 16629417
[TBL] [Abstract][Full Text] [Related]
14. Antioxidative enzymes activity and malondialdehyde concentration during mitoxantrone therapy in multiple sclerosis patients.
Adamczyk-Sowa M; Sowa P; Pierzchala K; Polaniak R; Labuz-Roszak B
J Physiol Pharmacol; 2012 Dec; 63(6):683-90. PubMed ID: 23388485
[TBL] [Abstract][Full Text] [Related]
15. Increased plasma 8,12-iso-iPF2alpha- VI levels in relapsing multiple sclerosis patients are not predictive of disease progression.
Teunissen CE; Sombekke M; van Winsen L; Killestein J; Barkhof F; Polman CH; Dijkstra CD; Blankenstein MA; Pratico D
Mult Scler; 2012 Aug; 18(8):1092-8. PubMed ID: 22695538
[TBL] [Abstract][Full Text] [Related]
16. GFAP in early multiple sclerosis: A biomarker for inflammation.
Kassubek R; Gorges M; Schocke M; Hagenston VAM; Huss A; Ludolph AC; Kassubek J; Tumani H
Neurosci Lett; 2017 Sep; 657():166-170. PubMed ID: 28802830
[TBL] [Abstract][Full Text] [Related]
17. C/EBP homologous protein investigation in the serum and cerebro-spinal fluid of relapsing-remitting multiple sclerosis patients.
Karami M; Aleagha MSE; Seidkhani-Nahal A; Bakhtiyari S; Noori-Zadeh A; Harirchian MH; Siroos B; Balood M; Khosravi A
J Clin Neurosci; 2019 Jan; 59():51-54. PubMed ID: 30446370
[TBL] [Abstract][Full Text] [Related]
18. Fatigue scores correlate with other self-assessment data, but not with clinical and biomarker parameters, in CIS and RRMS.
Håkansson I; Johansson L; Dahle C; Vrethem M; Ernerudh J
Mult Scler Relat Disord; 2019 Nov; 36():101424. PubMed ID: 31586802
[TBL] [Abstract][Full Text] [Related]
19. Serum and cerebrospinal fluid nitrite and nitrate levels in relapsing-remitting and secondary progressive multiple sclerosis patients.
Yuceyar N; Taşkiran D; Sağduyu A
Clin Neurol Neurosurg; 2001 Dec; 103(4):206-11. PubMed ID: 11714562
[TBL] [Abstract][Full Text] [Related]
20. CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis.
Fainardi E; Rizzo R; Melchiorri L; Stignani M; Castellazzi M; Tamborino C; Paolino E; Tola MR; Granieri E; Baricordi OR
Mult Scler; 2008 May; 14(4):446-54. PubMed ID: 18208868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
